HENLIUS (02696.HK) Latest Stock News - Major News Analysis

Quote List Quote List

Event Tracking

Dec3

Fanhom Hanlin Obtains Exclusive Commercialization Rights from AoHong Pharmaceutical

13:49

Dec2

Ful hon Han 霖's New Drug HLX14 Accepted for Review by National Medical Products Administration

10:33

Dec1

Fosun Pharma Subsidiary Receives NMPA Approval for HLX37 Injection Clinical Trials

09:08

Nov27

Taikang Life Insurance Buys Stake in Henlius H Shares

22:49

Nov25

Taikang Insurance Increases Holdings in Junshi Biosciences by 518,500 Shares

11:03

Fuzhonghannling Initiates Phase 1 Clinical Trial for Ipiumab Biosimilar HLX13

08:56

Schedules & Filings

Schedules

Filings

Aug25

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 1.543 B, Net Income 213.5 M, EPS 0.3928

Mar24

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 1.584 B, Net Income 230.95 M, EPS 0.4249

Aug26

Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 1.475 B, Net Income 207.55 M, EPS 0.3814

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change